DHHS Implements Common Application for HIV Patient Assistance Programs

A common application that allows people with HIV to apply for financial assistance for drugs from multiple companies went into effect on September 12, 2012. Individuals should now be able to obtain a complete antiretroviral regimen with a single form.

Merck Expands Co-pay Assistance Program for Raltegravir (Isentress)

Merck announced last week that it has expanded its co-pay assistance program for the integrase inhibitor raltegravir (Isentress). The program will now offer assistance for eligible patients with private insurance who have out-of-pocket copays.

Welcome to the New HIVandHepatitis.com

Our new design enables us to offer multimedia content and faster news reports and conference coverage.  

We have already started featuring work by new writers, and we will soon offer video content as well as text.

Our mission remains the same as it was when Ronald Baker founded HIVandHepatitis.com in 1999: to produce high-quality, accurate, and timely online information about treatment, management, and prevention of HIV infection, chronic hepatitis B and C, HIV/HBV and HIV/HCV coinfection, and related infectious diseases.

Earlier this year, after more than a decade, Ron decided to retire from his work with HIVandHepatitis.com. The role of editor-in-chief and publisher was assumed by Liz Highleyman, senior writer for the site since 2006. Liz got involved with AIDS activism in ACT UP/Boston in the late 1980s and has been a freelance medical writer focusing on HIV and hepatitis for more than 10 years.

HIV treatment has advanced remarkably since the 1990s. Today, in addition to following experimental drugs in development, much of our HIV/AIDS content focuses on management of associated conditions such as cardiovascular disease and other age-related issues -- as well as the renewed search for a cure.

With the approval last month of the first direct-acting drugs for hepatitis C, treatment for that disease, too, is undergoing a revolutionary shift. HIVandHepatitis.com will continue to bring you news of the latest developments in that area, as well as treatment for hepatitis B and HIV/hepatitis coinfections.

Please bear with us, as the new website is a work in progress. Over the next several months we will be adding more legacy content from the original site. If you are seeking specific older content, such as prior year conference coverage, you can still reach the old site at http://hivandhepatitis.com/legacysite.

We hope you enjoy the new HIVandHepatitis.com and find it useful. Send us email, visit our Facebook page, follow our Twitter feed, and watch our YouTube channel using the icons in the top menu bar on each page. Don't hesitate to send us feedback and suggestions for improvements!

7/12/11

ViiV Healthcare Announces Southern Initiative Grant Recipients